MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from public
offerings, net of issuance...
$13,578K
Proceeds from private
offerings, net of issuance...
$4,597K
Proceeds from equity line
financing
$795K
Net cash provided by
financing activities
$18,970K
Net decrease in cash
and cash...
-$9,976K
Canceled cashflow
$18,970K
Change in fair value of
revenue interest...
-$9,090K
Change in fair value of
debt
$3,615K
Stock-based compensation
$3,146K
Provision for
uncollectible accounts
$2,847K
Issuance costs
associated with warrants...
$1,502K
Provision for inventory
$1,216K
Depreciation and
amortization
$983K
Accounts receivable
-$844K
Prepaid expenses, other
current and long-term...
-$800K
Non-cash lease expense
$679K
Loss on
extinguishment of debt
-$660K
Change in fair value of
rtw share...
$370K
Net cash used in
operating activities
-$28,946K
Canceled cashflow
$25,752K
Revenue
$15,230K
Other segment items
$1,401K
Net loss
-$28,755K
Change in fair value of
warrant liabilities
-$12,800K
Canceled cashflow
$16,631K
Accrued expenses and
other current...
-$5,045K
Accounts payable
-$3,141K
Interest paid on debt
recorded at fair value
$2,410K
Change in fair value of
earn-out liabilities
$1,059K
Lease liabilities
-$796K
Inventory
$486K
Unrealized exchange gain
(loss) and other
$206K
General and
administrative
$21,353K
Sales and marketing
$10,804K
Cost of revenue
$5,659K
Research and
development-Clinical Trials And...
$3,020K
Research and
development-Product Development
$1,848K
Research and
development-Quality And Regulatory
$1,733K
Research and
development-Digital
$969K
Back
Back
Cash Flow
source: myfinsight.com
ALLURION TECHNOLOGIES, INC. (ALURW)
ALLURION TECHNOLOGIES, INC. (ALURW)